Collegium Pharma
Presencia
Collegium Pharma es una de las ...
Collegium Pharma es una empresa que cotiza bajo el símbolo de cotización COLL (US).
Ejecutivos
Ver el organigrama con sus 16 ejecutivos principales
Biografías más buscadas en Collegium Pharma
- Michael Heffernan, Interim President and Chief Executive Officer
- Neil McFarlane, Director
- Gwen Melincoff, Director
Recientes movimientos de ejecutivos en Collegium Pharma
- Michael Heffernan, se ha incorporado a la empresa como Interim President and Chief Executive Officer (noticia publicada el 10 de mayo de 2024).
- Joseph Ciaffoni, Director, President and Chief Executive Officer, ha dejado la empresa (noticia publicada el 10 de mayo de 2024).
Crear su alerta
para seguir los movimientos de los ejecutivos en Collegium Pharma.
Farmacia
Collegium Pharma tiene 1.860 competidores entre los que se incluyen Pfizer (Estados Unidos), Johnson & Johnson (Estados Unidos) y Sanofi (Francia).
Popular M&A news in Farmacia
- MedMen has filed for bankruptcy protection (publicado el 28 de abril de 2024).
- AstraZeneca has announced the acquisition of Fusion Pharma (publicado el 23 de marzo de 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (publicado el 19 de marzo de 2024).
Otros contactos sugeridos en el sector Farmacia
Noticias
Últimos comunicados de prensa de Collegium Pharma
- Collegium to Report Second Quarter 2022 Financial Results on August 4, 2022 - Collegium Pharmaceutical Inc.
- Collegium to Participate in H.C. Wainwright Global Investment Conference - Collegium Pharmaceutical Inc.
- Collegium Reports First Quarter 2022 Financial Results - Collegium Pharmaceutical Inc.
- Collegium to Host Conference Call to Discuss First Quarter 2022 Financial Results - Collegium Pharmaceutical Inc.
- Collegium Announces Settlement with Teva Resolving Xtampza® ER Patent Litigation - Collegium Pharmaceutical Inc.
- Collegium Appoints Rita Balice-Gordon to its Board of Directors - Collegium Pharmaceutical Inc.
- Collegium Announces Five Posters Presented at PAINWeek 2020 National Conference - Collegium Pharmaceutical Inc.
- Collegium Announces Scientific Presentations at PAINWeek 2020 National Conference - Collegium Pharmaceutical Inc.
- Collegium Reports Net Income of $8.1 Million in the Second Quarter of 2020 - Collegium Pharmaceutical Inc.
- Collegium to Host Conference Call to Discuss Second Quarter 2020 Financial Results and Provide Corporate Update - Collegium Pharmaceutical Inc.
- View more press releases Close
Redes sociales sobre Collegium Pharma
- Collegium Pharma en Wikipedia, Google News y Yahoo Finance
- Collegium Pharma en LinkedIn, Twitter y YouTube
Ponerse en contacto
Contactar a través de e-mail con sus ejecutivos Thomas Smith 
Llame a Collegium Pharma al +1 781...
